Drugs / AC591
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06722950 | Dec 2024 → Dec 2026 expected | colorectal adenoma | Shandong New Time Pharmaceutical Co., LTD | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AC591 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06722950 ↗ |
| Route | Oral | “AC591 : 3 times a day (daily), taken with boiled water.” NCT06722950 ↗ |